Meyer Andrew Hollman 4
4 · Janux Therapeutics, Inc. · Filed Jan 2, 2026
Insider Transaction Report
Form 4
Meyer Andrew Hollman
Chief Business Officer
Transactions
- Sale
Common Stock
2026-01-02$13.73/sh−1,879$25,799→ 83,095 total
Footnotes (1)
- [F1]The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units.